IDENTIFICATION OF NOVEL SEQUENCES OF THE ERVMER34-1 HUMAN ENDOGENOUS RETROVIRAL SEQUENCE FAMILY, AND MODIFICATION OF THOSE SEQUENCES FOR A MORE EFFECTIVE ANTI-CANCER VACCINE AND OTHER POTENTIAL ANTI-CANCER THERAPIES
Technology
E-056-2023
Patent ID
E-056-2023-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/527,895
IC
NCI
Date Filed
Date Issued
Patent PDF